Zenas BioPharma, Inc. Cash and Cash Equivalents
Zenas BioPharma, Inc. (ZBIO) had Cash and Cash Equivalents of $196.58 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $196.58M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $500.22M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $110.64M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $115.56M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $196.58M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $500.22M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $110.64M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $115.56M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $44.01M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $196.55M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $319.74M 10-K · filed 2026-03-16 |
| 2024-09-30 | $360.04M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $183.93M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $37.15M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $56.86M 10-K · filed 2025-03-11 |
| 2023-09-30 | $72.31M 10-Q · filed 2024-11-12 |